Literature DB >> 2992846

Augmentation of the response to CRF in man: relative contributions of endogenous angiotensin and vasopressin.

S R Milsom, J V Conaglen, R A Donald, E A Espiner, M G Nicholls, J H Livesey.   

Abstract

The plasma ACTH response to corticotrophin releasing factor (CRF) was studied in seven normal individuals. Five subjects were restudied following 4 d of salt restriction which resulted in raised endogenous plasma angiotensin II secretion. In a third experiment six subjects were given CRF following pre-infusion of hypertonic saline which significantly increased endogenous plasma vasopressin (AVP) levels. We were unable to demonstrate that high endogenous plasma AII levels were associated with a significant change in the plasma ACTH or cortisol responses to CRF. However there was an almost three-fold increase in the ACTH response when endogenous plasma AVP was elevated by hypertonic saline. It is concluded that AVP is likely to be of physiological importance in potentiating the ACTH response to CRF and that AVP and CRF together may provide a better test of pituitary ACTH secretion than either peptide alone.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2992846     DOI: 10.1111/j.1365-2265.1985.tb02998.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  5 in total

1.  Inferior petrosal sinus sampling in healthy subjects reveals a unilateral corticotropin-releasing hormone-induced arginine vasopressin release associated with ipsilateral adrenocorticotropin secretion.

Authors:  K T Kalogeras; L K Nieman; T C Friedman; J L Doppman; G B Cutler; G P Chrousos; R L Wilder; P W Gold; J A Yanovski
Journal:  J Clin Invest       Date:  1996-05-01       Impact factor: 14.808

2.  The plasma interleukin-6 and stress hormone responses to acute pyelonephritis.

Authors:  R A Donald; R R Bailey; D Hart; J H Livesey; M J Evans; L Mattioli; J Macdonald; A H Smith
Journal:  J Endocrinol Invest       Date:  1994-04       Impact factor: 4.256

3.  Metyrapone induced increase in plasma corticotropin is not associated with changes in peripheral venous arginine vasopressin or corticotropin releasing factor.

Authors:  S J Holmes; C M Florkowski; M J Evans; M J Ellis; J H Livesey; R A Donald; E A Espiner
Journal:  J Endocrinol Invest       Date:  1993-11       Impact factor: 4.256

4.  Vasopressin stimulation of adrenocorticotropin hormone (ACTH) in humans. In vivo bioassay of corticotropin-releasing factor (CRF) which provides evidence for CRF mediation of the diurnal rhythm of ACTH.

Authors:  R A Salata; D B Jarrett; J G Verbalis; A G Robinson
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

Review 5.  The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department.

Authors:  Christian H Nickel; Roland Bingisser; Nils G Morgenthaler
Journal:  BMC Med       Date:  2012-01-20       Impact factor: 8.775

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.